THIS SUPPLY
AGREEMENT (the “Agreement”) is made as of
January 1, 2006 (the “Effective Date”), by and
between Mead Johnson & Company, a corporation organized under
the laws of Delaware with offices located at 2400 West Lloyd
Expressway, Evansville, Indiana 47721 (“PURCHASER”),
and Martek Biosciences Corporation, a Delaware corporation with
offices located at 6480 Dobbin Road, Columbia, Maryland 21045
(“SELLER”).
WHEREAS, PURCHASER
and SELLER entered into a License Agreement dated as of
October 28, 1992 and amended by letter agreement dated
January 21, 2004 *, which License Agreement is amended by this
Agreement solely to the extent expressly provided herein (as so
amended, the “License Agreement”) wherein SELLER has
granted to PURCHASER in the Territory (as defined therein) certain
rights under Licensed Patents (as defined therein) and Technology
(as defined therein) (A) to produce the Mead Johnson Product
(as defined therein), (B) to use and make the Martek Product
(as defined therein) for purposes of making and having made the
Mead Johnson Product and (C) to use, market and distribute
directly or indirectly the Mead Johnson Product, in each case as
further specified in the License Agreement; and
WHEREAS, PURCHASER
wishes to purchase the Martek Product from SELLER; and
WHEREAS, SELLER is
willing to supply Martek Product for use by PURCHASER to
manufacture, use, market and distribute the Mead Johnson Product in
accordance with the terms of the License Agreement; and
WHEREAS, such
purchase and supply of Martek Product shall be subject to the terms
and conditions set forth in this Agreement.
NOW, THEREFORE, in
consideration of the foregoing premises and of the mutual
undertakings herein contained, the parties agree as
follows:
Unless defined
herein, all capitalized terms will have the meaning stated in the
License Agreement, as amended hereby. References herein to SELLER
and PURCHASER shall also be deemed as references to Licensor and
Licensee, respectively, for purposes of the License
Agreement.
1.1
“ARA” shall mean arachidonic acid.
1.2 “Annual
Forecast” shall have the meaning specified in
Section 2.2.1.
1.3
“DHA” shall mean docosahexaenoic acid.
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
1.4
“LCPUFA” shall mean any fatty acid, other than linoleic
acid, gammalinolenic acid and alphalinolenic acid, which contains
at least eighteen (18) carbon atoms and at least two
(2) double bonds.
1.5 “Martek
Product Specifications” shall mean the specifications for the
Martek Product to be supplied hereunder, as set forth in
Exhibit C attached hereto, as such Exhibit may be modified by
written agreement of the parties.
1.6 “Unit of
the Martek Product” shall mean that quantity of Martek
Product containing one (1) kilogram of DHA and/or ARA.
1.7 “Infant
Formula Product” shall mean an enteral product formulated for
the nutritional support of premature infants and/or a breast milk
substitute formulated industrially in accordance with applicable
Codex Alimentarius and United States Food and Drug Administration
standards to satisfy the total normal nutritional requirements of
infants up to between four and six months of age and adapted to
their physiological characteristics and fed in addition to other
foods to infants up to approximately one year of age.
ARTICLE 2.
PURCHASE AND SUPPLY OF COMPOUNDS
2.1
Purchase . (a) During the Term of this Agreement and
subject to the terms of this Agreement, PURCHASER shall purchase
and/or shall direct the Designee(s) (as defined in Exhibit B
hereto) to purchase, from SELLER, PURCHASER’s total
requirements of DHA and ARA as required by PURCHASER for use in
Infant Formula Products in accordance with the terms of the License
Agreement as amended hereby. All quantities of the Martek Product
purchased by PURCHASER or any Designee under this Agreement shall
be used solely for purposes of production, distribution and/or sale
of the Mead Johnson Product.
(b) As
partial consideration for the rights granted to PURCHASER
hereunder, including without limitation the pricing provisions and
price protection provided in Exhibit A attached hereto,
PURCHASER agrees that during the Term of this Agreement
Section 2.2 (i) of the License Agreement shall be of no
force or effect, and after the Term of this Agreement,
Section 2.2(i) of the License Agreement shall only apply with
respect to actions which occur after the Term of this Agreement.
Notwithstanding the above, to the extent PURCHASER elects to add
new countries to the Territory after the Effective Date of this
Agreement, the incremental additional License Fee cost to PURCHASER
shall be *, after the Effective Date of this Agreement, to *,
provided that SELLER has established specific License Fees for
those particular countries.
2.2 Forecasts
and Orders .
2.2.1 On the
Effective Date of this Agreement, PURCHASER shall give SELLER
written notice of the quantity of Martek Product which PURCHASER
estimates in good faith that it will order or direct the
Designee(s) to order from SELLER during the remainder of the
current calendar year (the “Initial Annual Forecast”).
Not later than November 30 of each calendar year during the
Term of this Agreement, PURCHASER shall give SELLER written notice
of the quantity of Martek Product which PURCHASER estimates in good
faith that it will order or direct the Designee(s) to
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 2 -
order from
SELLER during the next subsequent calendar year (each, an
“Annual Forecast”). The Annual Forecast shall be used
to establish the per unit and per kilogram pricing for the Martek
Products purchased during the relevant calendar year in accordance
with Section 2.3.1 and Exhibit A attached hereto;
provided that, for the remainder of calendar year 2006, the per
kilogram pricing to be used, subject to the year-end adjustment
pursuant to Section 2.3.1, shall be * per kilogram,
notwithstanding the Initial Annual Forecast. In addition to the
foregoing, one (1) month before the commencement of each
calendar quarter during the Term of this Agreement, PURCHASER shall
provide SELLER with a forecast (a “Rolling Forecast”)
of PURCHASER’s requirements for the Martek Product for each
of the succeeding four (4) quarters, specifying quantities and
requested delivery dates. These forecasts will be PURCHASER’s
good-faith, best estimate of requirements and should not be
considered a firm commitment.
2.2.2 PURCHASER
expressly acknowledges that available supplies of the Martek
Product have been in the past, and, may from time to time in the
future, be insufficient to meet current demand. Nevertheless,
SELLER shall use commercially reasonable efforts to have available
for shipment to PURCHASER or to a Designee for PURCHASER’s
account such quantities of the Martek Product as PURCHASER
forecasts in good faith pursuant to Section 2.2.1 above and
any additional quantities which PURCHASER may reasonably request.
In case for any reason SELLER cannot or does not supply such
quantities of the Martek Products as are forecasted in good faith
by PURCHASER pursuant to Section 2.2.1 to PURCHASER, PURCHASER
shall be allowed to use an alternative supplier for quantities of
Omega-3 and Omega-6 long-chain polyunsaturated fatty acids equal to
those quantities of Martek Products that were ordered by PURCHASER
pursuant to a Purchase Order and not delivered by
SELLER.
2.2.3 PURCHASER
shall issue and/or shall direct the Designee(s) to issue formal
purchase orders (“Purchase Orders”) at least sixty
(60) but no more than ninety (90) days in advance of the
date on which PURCHASER or the Designee requests that SELLER ship
the Martek Product. SELLER shall accept or reject any such Purchase
Order within five (5) business days of receipt, provided that
SELLER shall not reject any Purchase Order for any quantities
within the most recent forecast.
2.2.4 Purchase
Orders which have been accepted by SELLER shall be considered as
firm and binding orders (subject to the provisions of
Section 2.2.2 above) and shall only be canceled or amended by
mutual written agreement of the parties.
2.3.1 Price
. During the Term of this Agreement, PURCHASER and the Designee(s)
shall pay for the Martek Product in any order submitted by
PURCHASER or a Designee in accordance with the terms set forth in
Exhibit A attached hereto. PURCHASER hereby covenants and
agrees to abide by the conditions set forth on Exhibit A, as
amended by mutual agreement from time to time, which shall be
applicable to the Martek Product delivered to PURCHASER or a
Designee pursuant to the relevant Purchase Order, and PURCHASER
shall acknowledge in writing to SELLER, within thirty (30) days
after each calendar year-end, that PURCHASER has complied with this
covenant during the preceding twelve (12) month period. Price
calculations based on annual ordering volumes shall be made using
the Annual Forecasts submitted to SELLER by PURCHASER in accordance
with Section 2.2.1 and as further demonstrated in
Exhibit A-1 attached hereto. At the end of each
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 3 -
calendar year,
if the quantity actually purchased (as reflected in Purchase Orders
accepted by SELLER that satisfy the requirements of
Section 2.2 3 above and which are scheduled for shipment
within the corresponding calendar year) is less than the quantity
specified in the Annual Forecast for the relevant calendar year,
SELLER shall invoice PURCHASER within thirty (30) days after
the end of the calendar year for an amount equal to the difference,
if any, between the total price paid, and the total purchase price
payable for the quantity of Martek Product actually purchased from
SELLER in such calendar year as specified in Exhibit A.
Alternatively, if the quantity actually purchased during a calendar
year exceeds the quantity specified in the Annual Forecast for
purchase in such calendar year, SELLER shall credit against future
purchases of Martek Product by PURCHASER from SELLER an amount
equal to the difference, if any, between the total purchase price
payable for the quantity actually purchased as specified in
Exhibit A and the total price paid by PURCHASER, provided that
if this AGREEMENT has terminated, SELLER shall, in lieu of any such
credit, pay such amount to PURCHASER. Notwithstanding the
foregoing, for calendar year 2006, the year-end reconciliation
described above shall be calculated as of December 1, 2006
based on actual shipments in 2006 prior to such date, plus
shipments which are, as of December 1 st ,
2006, scheduled to occur in December 2006, and any resulting
credit shall be applied to invoices issued in December 2006,
and if any balance is remaining, payment shall be issued prior to
December 31 st ,
2006.
2.3.2 Taxes
. The purchase price for the Martek Product is exclusive of any and
all national, state or local sales, use, value added or other
taxes, customs duties and similar tariffs and fees which SELLER or
its Affiliates may be required to pay or collect upon the delivery
of the Martek Product, or otherwise. Should any tax or levy be
made, PURCHASER agrees to pay such tax or levy and indemnify SELLER
for any claim for such tax or levy demanded.
2.3.3 Terms and
Guarantee . PURCHASER and the Designee(s), as applicable, shall
pay all correct invoices for amounts due in accordance with
Section 2.3.1 above in the United States in U.S. dollars
within * days from the postmark date or date of electronic
transmission, or transmission by facsimile, as applicable, of
SELLER’s invoice, which invoice shall not be deemed to be
delivered earlier than the date of delivery of the invoiced Martek
Product. For any invoices containing invoicing errors, payment
shall not be due with respect to the incorrect portions of the
invoice only until the invoicing errors are corrected and a new
invoice, with respect to the incorrect portions on the original
invoice, is received by PURCHASER. In order to induce SELLER to
fill orders for the Martek Product placed by the Designees,
PURCHASER hereby assumes responsibility for, and unconditionally
guarantees, the timely payment of amounts due from the Designees
(the “Guaranteed Obligations”) within * days after
receipt from SELLER of notice of nonpayment of any such amount.
SELLER shall not be required, prior to any such notice to
PURCHASER, to pursue or exhaust any of its rights or remedies
against a defaulting Designee with respect to performance of any
Guaranteed Obligation.
2.3.4 Sample
Analysis . SELLER shall have the right to analyze samples of
the Mead Johnson Product at any time and from time to time for
purposes of verifying that PURCHASER has complied with any
conditions that may be applicable to the PURCHASER pursuant to the
terms of this Agreement, including its exhibits and appendices, for
any order of Martek Product. The expenses of such analyses shall be
borne by SELLER; provided, however, that PURCHASER shall provide
reasonable samples to SELLER without charge upon SELLER’s
request, to be made no more often than quarterly, and provided,
further, that PURCHASER shall be charged for, and
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 4 -
shall promptly
pay the expense of any such analysis that discloses a failure to
comply with any applicable condition.
2.4
Order and Delivery Terms .
2.4.1
Martek Product shall be delivered F.O.B. SELLER’s place of
shipment to PURCHASER or Designee, as specified in the applicable
Purchase Order.
2.4.2
Title to and risk of loss of Martek Product shall be transferred to
PURCHASER upon delivery by SELLER to a carrier for shipment to
PURCHASER or the indicated Designee.
2.4.3
In connection with ordering and delivering the Martek Product
hereunder, PURCHASER’s standard forms shall govern each
order; however, nothing in such forms shall be construed to bind
SELLER in any way that modifies or contradicts any express term of
this Supply Agreement or its exhibits and appendices.
ARTICLE 3.
REPRESENTATIONS, WARRANTY AND DISCLAIMER .
3.1
SELLER warrants that the Martek Product will be manufactured in
compliance with (1) current good manufacturing practices
promulgated by the U.S. Food and Drug Administration, (2) in
accordance with the requirements of Article 5.2 herein and
(3) in accordance with the Martek Product Specifications.
Except as otherwise provided in Section 8.2, the exclusive
liability of SELLER, and PURCHASER’s exclusive remedy, for
failure of any Martek Product to conform to the Martek Product
Specifications shall be the replacement of the nonconforming Martek
Product or a refund of the purchase price paid by PURCHASER for the
nonconforming Martek Product (including duty, freight, insurance
charges, and other similar related expenses) at the SELLER’s
sole option.
3.2
SELLER’s Representations and Warranties . SELLER
represents and warrants to the PURCHASER as follows:
(i) Exhibit D
attached hereto sets forth a complete and accurate list of the
Licensed Patents as of the date of this Agreement.
(ii) SELLER
has all necessary corporate power and authority to enter into this
Agreement and perform its obligations hereunder.
(iii) SELLER’s
performance under this Agreement does not conflict with any other
contract to which SELLER is bound.
3.3
SELLER’s Disclaimers .
3.3.1
EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, SELLER HEREBY
DISCLAIMS ANY AND ALL WARRANTIES, EXPRESS AND IMPLIED, INCLUDING
WITHOUT LIMITATION ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A
PARTICULAR PURPOSE AND NONINFRINGEMENT, RELATING TO
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 5 -
THE TECHNOLOGY,
THE MARTEK PRODUCTS OR THE MARTEK TRADEMARKS. SELLER MAKES NO
REPRESENTATIONS OR WARRANTIES AND HAS NO DUTY TO ENSURE THAT THE
TECHNOLOGY OR THE MARTEK PRODUCTS ARE USABLE WITH THE MEAD JOHNSON
PRODUCT OR THAT THE MARTEK PRODUCTS ARE SAFE OR CAN BE INCORPORATED
SAFELY INTO THE MEAD JOHNSON PRODUCT. IT IS HEREBY ACKNOWLEDGED AND
AGREED THAT IT SHALL BE PURCHASER’S RIGHT AND OBLIGATION TO
DETERMINE THE SAFETY AND UTILITY OF THE MARTEK PRODUCTS AS THEY
RELATE TO EACH MEAD JOHNSON PRODUCT.
3.3.2 SELLER
HEREBY DISCLAIMS ANY WARRANTY THAT SELLER’S RIGHTS IN THE
TECHNOLOGY OR USE OF THE MARTEK PRODUCT ARE FREE FROM INFRINGEMENT
BY THIRD PARTIES. SELLER FURTHER DISCLAIMS ANY WARRANTY RELATING TO
THE PATENTABILITY OF, OR THE VALIDITY OF ANY PATENTS RELATING TO,
THE TECHNOLOGY, OR THE MARTEK PRODUCT AND MAKES NO REPRESENTATIONS
WHATSOEVER WITH REGARD TO THE SCOPE OF ANY LICENSED PATENTS OR THAT
ANY LICENSED PATENTS MAY BE COMMERCIALLY EXPLOITED WITHOUT
INFRINGING OTHER PATENTS.
3.3.3 EXCEPT AS
EXPRESSLY SET FORTH IN THIS AGREEMENT, SELLER HEREBY DISCLAIMS AND
SHALL NOT BE LIABLE FOR ANY DAMAGES OF ANY NATURE RESULTING OR
ARISING FROM OR RELATING TO (A) THE USE, MANUFACTURE,
DISTRIBUTION, MARKETING, OR SALE BY PURCHASER, ITS AFFILIATES OR
ANY THIRD PARTY OF THE TECHNOLOGY, THE MARTEK PRODUCT, OR THE MEAD
JOHNSON PRODUCTS, OR (B) ANY IMPROVEMENTS OR MODIFICATIONS TO
THE TECHNOLOGY, THE MARTEK PRODUCT, OR THE MEAD JOHNSON PRODUCTS
WHICH ARE NOT MADE BY AND PROPRIETARY TO SELLER,
[
3.3.4
PURCHASER’s Warranties . PURCHASER represents and
warrants to the SELLER as follows:
|
|
(i)
|
|
The
execution and delivery of this Agreement and the performance by
PURCHASER of the transactions contemplated hereby have been duly
authorized by all necessary corporate actions.
|
|
|
(ii)
|
|
The
performance by PURCHASER of any of the terms and conditions of this
Agreement will not constitute a breach or violation of any other
agreement or understanding, written or oral, to which it or its
Affiliates is a party.
|
ARTICLE 4.
TERM, TERMINATION
4.1 Term :
This Agreement shall commence on the Effective Date and, subject to
prior termination of this Agreement in accordance with the terms
hereof, shall terminate on the tenth (10 th )
anniversary of the Effective Date (the
“Term”).
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 6 -
4.2.1
Termination in Case of Material Breach; Opportunity to Cure
. Either party to this Agreement may terminate this Agreement upon
sixty (60) days prior written notice if the other party shall
commit a material breach of this Agreement and shall not cure such
breach within such sixty (60) day period.
4.2.2
Termination in Case of Infringement . PURCHASER shall have
the right to terminate this Agreement in a particular jurisdiction
within the Territory if the parties receive a written opinion of a
mutually agreeable outside patent counsel, or a court or other
tribunal of competent jurisdiction determines by final order, that
the Technology or any material portion thereof or the Martek
Product infringe upon the patent or other proprietary rights of any
Third Party in such jurisdiction; provided, however, that if, prior
to any such termination, SELLER develops a non-infringing
alternative that is fully compliant with all applicable laws and
regulations and meets PURCHASER’S specifications and
requirements as a substitute for the Martek Product, or obtains a
license from such Third Party, such that PURCHASER could lawfully
use the Technology and/or the Martek Product (as the case may be)
in connection with the Mead Johnson Products at no additional cost
or expense to PURCHASER beyond that expressly provided in this
Agreement, PURCHASER shall not terminate this Agreement.
4.2.2.1 Volumes
in Case of Infringement Termination . In the event that
PURCHASER terminates this Agreement as to a particular jurisdiction
within the Territory based on Section 4.2.2, SELLER agrees to
annually credit the * of PURCHASER for the particular jurisdiction
to * used in determining PURCHASER’s * Schedule A for
future purchases of Martek Product.
4.2.3
Termination in Case of Insolvency; Government Action .
Notwithstanding any other provisions of this Agreement, either
party to this Agreement may terminate this Agreement upon giving
notice to the other, should the other commit an act of bankruptcy,
declare bankruptcy, be declared bankrupt, enter into an arrangement
for benefit of creditors, enter into a procedure of winding up or
dissolution, or should a trustee or receiver be appointed for the
other or upon the expropriation, takeover or nationalization of the
other party or a majority portion of its assets by governmental
action.
4.2.4 Other
Termination Rights . In addition to the termination rights set
forth above, either party may terminate this Agreement upon twelve
(12) months prior written notice provided that such notice
shall not be given until after the fifth (5
th ) anniversary of the Effective Date of this
Agreement.
4.2.5
Termination of License Agreement . This Agreement shall
automatically terminate in the event of the termination of the
License Agreement.
4.3 Effect of
Termination . Upon termination of this Agreement in its
entirety other than pursuant to Section 4.2.5 or on account of
PURCHASER’s breach of this Agreement, PURCHASER and its
Affiliates and Designees may continue to manufacture, produce, use,
market, offer for sale, sell, promote and distribute, to the extent
lawful, any Mead Johnson Products containing Martek Product
purchased hereunder until its inventory of such Mead Johnson
Products is exhausted. Upon termination of this Agreement pursuant
to Section 4.2.4 or on account of PURCHASER’s breach of
this Agreement,
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 7 -
SELLER shall
have the right, but not the obligation, to purchase from PURCHASER,
its Affiliates and Designees, at the cost paid for such Martek
Product, PURCHASER’s unused inventories of the Martek
Product.
4.4 Effect on
License Agreement . Upon termination of this Agreement,
notwithstanding any other provision hereof, the amendments to
Sections 2.2(i) (subject to the last phrase of the first
sentence of Section 2.1(b) hereof) , 4.1(ii), 4.1(iii),
6.1, 6.2, and 6.3 of the License Agreement as set forth herein
shall be of no further force or effect.
4.5 No
Royalties . As of the date of this Agreement, the parties
declare that no royalties are due from PURCHASER to SELLER under
the License Agreement for actions which have occurred prior to the
Effective Date or which occur during the Term of this Agreement
Furthermore, to SELLER’s knowledge without inquiry, PURCHASER
is current on all payments due to SELLER whether for license fees
or product delivered.
|
|
|
|
|
*
|
The asterisk
denotes that confidential portions of this exhibit have been
omitted in reliance on Rule 24b-2 of the Securities Exchange
Act of 1934. The confidential portions have been submitted
separately to the Securities and Exchange Commission.
|
- 8 -
5.1 During the
Term of this Agreement, Sections 6.1, 6.2 and 6.3 of the
License Agreement shall be deemed deleted in their entirety and
replaced with Sections 5.2, 5.3 and 5.4 below.
5.2 Compliance
with Law; Regulatory Approval . Each of SELLER and PURCHASER
(each for itself and on behalf of its Affiliates and Designees)
covenants and agrees that it shall conduct all of its operations
dealing with the Technology, the Martek Product and the Mead
Johnson Product, in material compliance with all applicable laws,
regulations and other requirements which may be in effect from time
to time, of all national governmental authorities, and of all
states, municipalities and other political subdivisions and
agencies thereof, including, without limiting the generality of the
foregoing, the Federal Food, Drug, and Cosmetic Act, the Infant
Formula Act of 1980, the regulations and other requirements of the
United States Food and Drug Administration, similar state laws and
regulations or similar laws and other requirements in the
Territory, including any and all amendments, as may be applicable
in any jurisdiction in the Territory in which any Martek Product,
or Mead Johnson Product, as applicable, is sold. It shall be
PURCHASER’s, and not SELLER’s, responsibility to secure
any regulatory approvals in the Territory that may be necessary in
connection with exercise by PURCHASER of the rights granted under
this Agreement, and in connection therewith, PURCHASER shall not
intentionally impair SELLER’s ability to obtain any
regulatory approval of the Martek Product by the competent
governmental authorities in any Territory and for any product that
SELLER may elect to pursue.
5.3 Performance
and Product Quality . PURCHASER covenants and agrees that it
and its Affiliates, and to the extent applicable, its Designees,
shall exercise a reasonable standard of care and quality control in
the testing, manufacturing, marketing, packaging, distribution and
sale of each Mead Johnson Product. PURCHASER further covenants and
agrees that it and its Affiliates
|